- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
Report FOCGO, TAMDEFLO – VINH DUC HOSPITAL
Friday, August 18, 2023, at Vinh Duc Hospital hall. CPDP Medbolide Company had a report introducing the NSAID pain reliever FOCGO (Lornoxicam 8mg) and the stomach medicine FOGICAP (Omeprazole and Sodium Bicarbonate). The report took place with the attendance of 70 Doctors and medical staff.
Company representatives presented recommendations and clinical research demonstrating the effectiveness of FOCGO, a COX1-COX2 balanced NSAID pain reliever that helps minimize cardiovascular and gastric side effects and has strong analgesic effect. . And the drug FOGICAP, is an FDA-approved immediate-release formulation of PPIs. The drug helps control stomach acid strongly, quickly and continuously for 24 hours.
After the report, the doctors had many discussions about the use and safety of the drug.
At the end of the report, Medbolide Company sends its thanks and hopes to continue accompanying the Hospital in bringing solutions to improve the quality of life for patients.
Readers comments